Hamilton Thomas Edward — SEC Form 4 filings
SEC reporting owner CIK 1769848. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-08.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-17 to 2026-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 207,208 shares, $1,166,888 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 100,000 shares @ $5.00 ($500,000) in Larimar Therapeutics, Inc., filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. (LRMR) | Director | 5 | 3 legs · 207,208 sh · $1,166,888 | — | 3 |
| ANNALY CAPITAL MANAGEMENT INC (NLY) | Director | 3 | — | — | 3 |
Form 4 filings — Hamilton Thomas Edward
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-08 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 50,000 @ $3.34 | EDGAR |
| 2026-06-12 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 8,641 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 100,000 @ $5 | EDGAR |
| 2025-05-15 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 8,961 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 57,208 @ $8.74 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 8,583 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1769848 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →